Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive.

Abstract:

BACKGROUND:Optic pathway gliomas (OPGs) are commonly noted in pediatric oncology services. Radiotherapy is effective at controlling tumors, but has many undesirable late effects, especially in patients with neurofibromatosis. Chemotherapy is commonly used to preserve vision and delay or eliminate the need for radiotherapy. Despite visual threat being a common reason to initiate chemotherapy in patients with OPG, reports of visual outcome after chemotherapy are not common and reports of long-term visual outcome are even scarcer. METHODS:In a single institution, all patients with OPG who had received chemotherapy or radiotherapy between 1996 and 2013 were identified from hospital databases. Visual, treatment, and radiological data were recorded. Categorized visual acuity was the primary outcome measure. RESULTS:Of 43 patients identified, visual data were available for 42 patients. Approximately 14% of patients experienced an improvement in visual acuity during therapy, 9% of patients experienced a deterioration, and the remainder were stable. At a mean follow-up of 78 months, 26% of patients were legally blind. Children aged <2 years and patients with a chiasmatic/hypothalamic tumor site were overrepresented in this category. An intraconal location was predictive of poor visual outcome for that eye but was unilateral with normal vision in the contralateral eye. CONCLUSIONS:Risk factors for long-term visual deterioration are young age, chiasmatic/hypothalamic tumor site, and intraconal tumor site for the involved eye. The most common visual outcome for children with OPG after treatment with chemotherapy is stability. This stability is maintained over the long term for >90% of children without these risk factors.

journal_name

Cancer

journal_title

Cancer

authors

Dodgshun AJ,Elder JE,Hansford JR,Sullivan MJ

doi

10.1002/cncr.29649

subject

Has Abstract

pub_date

2015-12-01 00:00:00

pages

4190-6

issue

23

eissn

0008-543X

issn

1097-0142

journal_volume

121

pub_type

杂志文章

相关文献

CANCER文献大全
  • Thromboprophylaxis with low-molecular-weight heparin in medical patients with cancer.

    abstract::Venous thromboembolism (VTE) is a frequent complication of cancer and cancer treatment and is associated with multiple clinical consequences, including recurrent VTE, bleeding, and an increase in the risk of death. Although the risks associated with VTE have been well recognized in surgical cancer patients, there is a...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.24665

    authors: Lyman GH

    更新日期:2009-12-15 00:00:00

  • Sequential half-body irradiation in lymphomatoid granulomatosis. Report of a case and an immunohistologic study.

    abstract::A case is presented of a man with ulcerating skin nodules who was diagnosed by histologic and immunohistologic analysis of skin biopsy specimens as having lymphomatoid granulomatosis (LYG). Phenotypic studies showed the majority of the infiltrating cells to be activated CD4+ T-lymphocytes. The disease followed a rapid...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890215)63:4<652::aid-cncr28206

    authors: Atkinson CH,Davis AL,Colls BM,Wolever TH,Burry AF,Hart DN

    更新日期:1989-02-15 00:00:00

  • Malignant peritoneal mesothelioma after remote abdominal radiation.

    abstract::Peritoneal mesothelioma in a 61-year-old man, occurred 26 years after abdominal radiotherapy for a testicular seminoma. The patient had no history of asbestos exposure. After asbestos, radiation is the second most frequent defined cause of mesothelioma in North America, but the number of well-documented cases is small...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19880515)61:10<2019::aid-cncr282

    authors: Gilks B,Hegedus C,Freeman H,Fratkin L,Churg A

    更新日期:1988-05-15 00:00:00

  • Patterns of locoregional treatment for nonmetastatic breast cancer by patient and health system factors.

    abstract:BACKGROUND:The purpose of this study was to examine local definitive therapy for nonmetastatic breast cancer with the Patterns of Care Breast and Prostate Cancer (POCBP) study of the National Program of Cancer Registries (Centers for Disease Control and Prevention). METHODS:POCBP medical record data were re-abstracted...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29092

    authors: Anderson RT,Morris CR,Kimmick G,Trentham-Dietz A,Camacho F,Wu XC,Sabatino SA,Fleming ST,Lipscomb J

    更新日期:2015-03-01 00:00:00

  • The diagnostic value of the hemoccult as a screening test in patients taking anticoagulants.

    abstract::The value of a 3-day Hemoccult II test in the diagnosis of colorectal disease in patients receiving anticoagulant therapy was studied. The influence of rehydration and nonrehydration of the slide was investigated, as well as the reproducibility of positive tests. Eight hundred forty-nine patients on anticoagulant ther...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19841215)54:12<3054::aid-cncr282

    authors: Kewenter J,Svanvik J,Svensson C,Wållgren K

    更新日期:1984-12-15 00:00:00

  • Gastrointestinal metastases from malignant tumors of the lung.

    abstract::Autopsy data of 423 cases of primary tumor of the lung over a 36-year period were evaluated for the presence of gastrointestinal tract metastases. Fifty-eight cases (14%) were found and were analyzed for histologic nature of tumor, anatomic location, symptomatology and complications. The most common histologic type of...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820101)49:1<170::aid-cncr28204

    authors: Antler AS,Ough Y,Pitchumoni CS,Davidian M,Thelmo W

    更新日期:1982-01-01 00:00:00

  • Meaningful endpoints for therapies approved for hematologic malignancies.

    abstract:BACKGROUND:Overall survival (OS) is considered the gold standard for determining treatment efficacy in oncology trials, but the relation between treatment and OS can be challenging to assess because of long study durations and the impact of subsequent therapies on outcome. Using OS can be particularly difficult for new...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.30622

    authors: Smith BD,DeZern AE,Bastian AW,Durie BGM

    更新日期:2017-05-15 00:00:00

  • Effects of hepatic arterial yttrium 90 glass microspheres in dogs.

    abstract::A 22-micron glass microsphere called TheraSphere (Theragenics Corp., Atlanta, GA) has been developed in which yttrium 89 oxide is incorporated into the glass matrix and is activated by neutron bombardment to form the beta-emitting isotope yttrium 90 (Y 90) before using the spheres as radiotherapeutic vehicles. The inj...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880401)61:7<1336::aid-cncr2820

    authors: Wollner I,Knutsen C,Smith P,Prieskorn D,Chrisp C,Andrews J,Juni J,Warber S,Klevering J,Crudup J

    更新日期:1988-04-01 00:00:00

  • Predictive and prognostic roles of ribonucleotide reductase M1 in resectable pancreatic adenocarcinoma.

    abstract:BACKGROUND:Ribonucleotide reductase M1 (RRM1) is an important molecule in different types of cancer. The objective of this study was to evaluate the predictive roles of RRM1 in the survival of patients with resectable pancreatic adenocarcinoma who received treatment with gemcitabine or nongemcitabine adjuvant therapy. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.27715

    authors: Xie H,Jiang W,Jiang J,Wang Y,Kim R,Liu X,Liu X

    更新日期:2013-01-01 00:00:00

  • Angiogenesis in adenocarcinoma of the uterine cervix.

    abstract:BACKGROUND:Angiogenesis is essential for tumor growth, progression, and metastases. Microvessel density (MVD), a measure of tumor angiogenesis, has been found to have prognostic significance in many tumor types for predicting metastasis and survival. METHODS:Between 1979-1989, 56 cases of FIGO Clinical Stage I and II ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19981001)83:7<1384::aid-cn

    authors: Kaku T,Hirakawa T,Kamura T,Amada S,Kinukawa N,Kobayashi H,Sakai K,Ariyoshi K,Sonoda K,Nakano H

    更新日期:1998-10-01 00:00:00

  • Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancer.

    abstract::Seventy patients with poor prognosis, metastatic breast cancer were treated with FUVAC induction chemotherapy (5-fluorouracil, vinblastine, Adriamycin [doxorubicin] and cyclophosphamide). Consolidation therapy was given to 30 of 48 responders (63%), of whom 23 received sequential hemibody irradiation (HBI) at 8 cGy, c...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870401)59:7<1249::aid-cncr2820

    authors: Livingston RB,Schulman S,Griffin BR,Tranum BL,Rivkin SE,Goldberg RS,Fabian CJ,Hammond N,Hynes H

    更新日期:1987-04-01 00:00:00

  • Molecular genetic alterations as potential prognostic indicators in colorectal carcinoma.

    abstract::The molecular genetic alterations in colorectal carcinoma are among the best understood of any common human cancer. Identified abnormalities include both dominant-acting oncogenes (ras, myc, src) and suppressor genes which undergo inactivation or deletion (deleted in colorectal carcinoma gene [DCC], p53, adenomatous p...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19920315)69:6+<1589::aid-cncr282

    authors: Hamilton SR

    更新日期:1992-03-15 00:00:00

  • Methotrexate and asparaginase combination chemotherapy in refractory acute lymphoblastic leukemia of childhood.

    abstract::Two groups of children with refractory acute lymphoblastic leukemia were treated with a regimen of methotrexate (MTX) and asparaginase (Asn'ase) based on studies of the effect of MTX in vitro on human lymphoblasts exposed to Asn'ase. Induction therapy in 12 children produced 4 complete remissions, 3 partial remissions...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197903)43:3<1089::aid-cncr282043

    authors: Lobel JS,O'Brien RT,McIntosh S,Aspnes GT,Capizzi RL

    更新日期:1979-03-01 00:00:00

  • Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.

    abstract:BACKGROUND:Transitional cell carcinoma (TCC) of the bladder displays an unpredictable biologic behavior and the morphologic methods of grading tumor malignancy are often insufficient to predict the clinical outcome of patients with TCC of the bladder. Thus, the new indicator should reliably reflect prognosis. In this s...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19961015)78:8<1762::aid-cn

    authors: Shiina H,Igawa M,Nagami H,Yagi H,Urakami S,Yoneda T,Shirakawa H,Ishibe T,Kawanishi M

    更新日期:1996-10-15 00:00:00

  • Survivorship after lower gastrointestinal cancer: Patient-reported outcomes and planning for care.

    abstract:BACKGROUND:There is significant need for quality follow-up care to optimize long-term outcomes for the growing population of lower gastrointestinal (GI) cancer survivors. Patient-reported outcomes (PROs) provide valuable information regarding late and long-term effects (LLTEs). METHODS:A convenience sample from 1129 c...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.30527

    authors: Frick MA,Vachani CC,Hampshire MK,Bach C,Arnold-Korzeniowski K,Metz JM,Hill-Kayser CE

    更新日期:2017-05-15 00:00:00

  • Characterization of laryngopharyngeal reflux in patients with premalignant or early carcinomas of the larynx.

    abstract:BACKGROUND:An association between laryngopharyngeal reflux (LPR) and laryngeal carcinoma has been suggested, but remains unproven. The current pilot study was performed to determine the incidence of LPR among patients with early laryngeal carcinomas or dysplasia and to examine the associations between levels of LPR and...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11158

    authors: Lewin JS,Gillenwater AM,Garrett JD,Bishop-Leone JK,Nguyen DD,Callender DL,Ayers GD,Myers JN

    更新日期:2003-02-15 00:00:00

  • Prognostic factors influencing relapse of squamous cell carcinoma of the maxillary sinus.

    abstract::In 95 surgically staged patients with squamous cell carcinoma of the maxillary sinus, multivariate regression analyses were employed to identify prognostic factors. Possible prognostic factors for local control were TNM stage and type of surgical procedures: T2 or T3 tumors and use of total maxillectomy showed better ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850101)55:1<190::aid-cncr28205

    authors: Kondo M,Ogawa K,Inuyama Y,Yamashita S,Tominaga S,Shigematsu N,Nishiguchi I,Hashimoto S

    更新日期:1985-01-01 00:00:00

  • A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study Group.

    abstract:BACKGROUND:A randomized, multicenter trial, double-blind for antiandrogen therapy, compared the antiandrogens bicalutamide and flutamide, each combined with luteinizing hormone-releasing hormone analogue therapy (LHRH-A) in 813 patients with Stage D2 prostate carcinoma. An analysis of time to progression (median follow...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1002/(sici)1097-0142(19961115)78:10<2164::aid-c

    authors: Schellhammer PF,Sharifi R,Block NL,Soloway MS,Venner PM,Patterson AL,Sarosdy MF,Vogelzang NJ,Chen Y,Kolvenbag GJ

    更新日期:1996-11-15 00:00:00

  • The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women. Clinical correlation on 547 patients.

    abstract::The aims of this study were as follows: to confirm that the presence of estrogen (ER) and progesterone (PgR) receptors is an indicator of clinical behavior of human breast cancer independent of other known prognostic factors; to seek clinical correlates of those receptor values that best predict the overall disease ev...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860315)57:6<1171::aid-cncr2820

    authors: Vollenweider-Zerargui L,Barrelet L,Wong Y,Lemarchand-Béraud T,Gómez F

    更新日期:1986-03-15 00:00:00

  • Interferon therapy for the treatment of renal cancer.

    abstract::Renal cell carcinoma (RCC) has remained refractory to substantive change of its natural history despite intervention with a number of therapeutic modalities. Alpha interferons leukocyte interferon alpha [HuIFN-alpha (Le)] and lymphoblastoid interferon alpha [HuIFN-alpha (Ly)] initially were shown to produce regression...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860415)57:8+<1696::aid-cncr282

    authors: Neidhart JA

    更新日期:1986-04-15 00:00:00

  • Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia.

    abstract:BACKGROUND:Aberrant expression of the facilitative glucose transporter, GLUT1, is found in a wide spectrum of epithelial malignancies. The current study describes an immunohistochemical study of GLUT1 expression in benign, hyperplastic, and malignant endometrial epithelia. METHODS:One hundred sixteen formalin fixed, p...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Wang BY,Kalir T,Sabo E,Sherman DE,Cohen C,Burstein DE

    更新日期:2000-06-15 00:00:00

  • Gender representation of cancer patients in medical treatment and psychosocial survivorship research: changes over three decades.

    abstract:BACKGROUND:Prior studies raise concern about gender bias in cancer research, including insufficient inclusion of women or men, or studying women and men differently. The 1993 National Institutes of Health Revitalization Act aimed to eliminate gender bias in medicine. To examine changes in medical and psychological lite...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.27432

    authors: Hoyt MA,Rubin LR

    更新日期:2012-10-01 00:00:00

  • Prognostic value of erb-B2 and myc amplification in breast cancer imprints.

    abstract:BACKGROUND:Amplification of erb-B2 and myc shows prognostic value in patients with operable breast cancer. Amplification is usually detected in tumor samples remaining after pathologic work-up, preventing the examination of small tumors. METHODS:Tumor imprints that contained low numbers of contaminating normal cells w...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19950601)75:11<2681::aid-cncr282

    authors: Lönn U,Lönn S,Nilsson B,Stenkvist B

    更新日期:1995-06-01 00:00:00

  • Viral oncolysate in the management of malignant melanoma. II. Clinical studies.

    abstract::Melanoma cell oncolysate, prepared with Newcastle disease virus, was administered as an immunostimulant to 13 patients with metastatic melanoma. The oncolysate was well tolerated. Six treated patients evidenced a decrease in the size of skin nodules or diseased lymph nodes. Visceral lesions were not favorably influenc...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197708)40:2<680::aid-cncr2820400

    authors: Murray DR,Cassel WA,Torbin AH,Olkowski ZL,Moore ME

    更新日期:1977-08-01 00:00:00

  • Breast carcinoma etiology: current knowledge and new insights into the effects of reproductive and hormonal risk factors in black and white populations.

    abstract:BACKGROUND:A crossover in breast carcinoma incidence at ages 45-49 years has been observed between black and white women, with blacks experiencing higher incidence at younger ages and lower incidence after age 50 years. Can this phenomenon be partially explained by the differences in the distributions of reproductive r...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/(sici)1097-0142(20000301)88:5+<1230::aid-c

    authors: Pathak DR,Osuch JR,He J

    更新日期:2000-03-01 00:00:00

  • Clinical application of estrogen receptor in breast cancer.

    abstract::Patients with ER positive primary tumors usually have initial metastases at the more favorable sites. Twelve out of 14 patients with ER positive had first site of metastases in either bone or soft tissue. In contrast, 13 of 17 patients with negative ER developed first metastases in viscera. ER positive patients respon...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19801215)46:12+<2932::aid-cncr28

    authors: Singhakowinta A,Saunders DE,Brooks SC,Samal B,Vaitkevicius VK

    更新日期:1980-12-15 00:00:00

  • Cyclophosphamide, vincristine, adriamycin, and prednisone (CHOP) with and without intermediate dose methotrexate for the treatment of non-Hodgkin's lymphomas of diffuse histology.

    abstract::Seventy three patients with disseminated diffuse non-Hodgkin's lymphomas were treated with combinations of cyclophosphamide, vincristine sulfate, prednisone, and doxorubicin with and without 2 weekly doses of oral methotrexate in "intermediate" doses, followed by calcium leucovorin rescue. The addition of methotrexate...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19870701)60:1<18::aid-cncr282060

    authors: Gomez GA,Barcos M,Han T,Henderson ES

    更新日期:1987-07-01 00:00:00

  • Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma.

    abstract::Seventeen patients with disseminated malignant melanoma received a daily oral regimen of tamoxifen, 100 mg/m2. All patients had prior chemotherapy and predominantly visceral involvement. None of the patients had an objective regression and most (71%) had progressive disease at the time of first reassessment. Moderate ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820401)49:7<1353::aid-cncr2820

    authors: Creagan ET,Ingle JN,Ahmann DL,Green SJ

    更新日期:1982-04-01 00:00:00

  • Non-Hodgkin's lymphomas of stage III extent. Is total lymphoid irradiation appropriate treatment?

    abstract::Many investigators have regarded Stage III lymphomas as a generalized form of disease and have accordingly recommended systemic treatment programs. Between 1961 and 1973, 68 patients with clinical or pathologic Stage III non-Hodgkin's lymphomas were seen in the Division of Radiation Therapy at Stanford University Medi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197606)37:6<2806::aid-cncr282037

    authors: Glatstein E,Fuks Z,Goffinet DR,Kaplan HS

    更新日期:1976-06-01 00:00:00

  • Pediatric cancer mortality and survival in the United States, 2001-2016.

    abstract:BACKGROUND:Although pediatric cancer mortality and survival have improved in the United States over the past 40 years, differences exist by age, race/ethnicity, cancer site, and economic status. To assess progress, this study examined recent mortality and survival data for individuals younger than 20 years. METHODS:Ag...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33080

    authors: Siegel DA,Richardson LC,Henley SJ,Wilson RJ,Dowling NF,Weir HK,Tai EW,Buchanan Lunsford N

    更新日期:2020-10-01 00:00:00